Navigation Links
Facial Plastic Surgeon Dr. Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Date:7/16/2009

WORCESTER, Mass., July 16 /PRNewswire/ -- Board-certified facial plastic surgeon Frank P. Fechner, M.D. has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines, to treat patients who are looking for a longer lasting dermal filler. Dr. Fechner has been an avid Artefill user the past several years due to its proven success and effectiveness for the correction of deep wrinkles.

"In our hands, Artefill has been proven to be a safe and effective dermal filler for patients looking to correct their nasolabial creases, with minimal maintenance requirements," said Dr. Fechner. "Due to the product's nature, Artefill's effect may last easily five years or longer. However, given the superior longevity of Artefill, we recommend 'meticulous technique and conservative placement of the filler' and routinely prepare our patients for two visits in order to achieve the desired improvements."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in New England and is not available at all physician offices. Dr. Fechner is one of the trained and select physicians who have the skills and experience needed to administer the product safely.

Jane Hansen, a patient of Dr. Fechner's said, "Prior to Artefill, I found myself constantly looking at my nasolabial folds. Since I had the treatment, I feel and look much better and I'm not constantly obsessing in the mirror anymore. I would do it again and would definitely refer Artefill to other patients."

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit www.artefill.com or www.sunevamedical.com.

About Dr. Frank P. Fechner:

Facial Plastic Surgeon Dr. Frank P. Fechner is Harvard-trained and double board certified with his private practice conveniently located in Worcester, Massachusetts. As a teacher at Harvard Medical School and UMass Medical School, he is affiliated with the Massachusetts Eye & Ear Infirmary in Boston and UMass Memorial Medical Center in Worcester, Massachusetts. Dr. Fechner is a renowned facelift expert who has been featured on ABC, NBC and other news outlets. Focusing exclusively on the face and neck, he performs both surgical and non-surgical procedures. On average, Dr. Fechner performs hundreds of facelifts and dermal filler treatments a year. For more information, please visit www.drfechner.com.

ATTENTION MEDIA: To download Artefill patient before and after pictures http://www.artefill.com/content/c/beforeandafter/overview.asp.

    Contact:
    Frank P. Fechner, MD
    428 Shrewsbury Street
    Worcester, MA 01604
    Tel. (508) 754-4000
   http://www.DrFechner.com


'/>"/>
SOURCE Dr. Frank P. Fechner
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp
2. Putting a name to a face may be key to brains facial expertise
3. Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu (D-LA) For Introducing Legislation to Require Insurance Coverage for Children With Congenital Deformities
4. BellaDerm(TM), a Unique Human Skin Tissue Implant for Facial and Body Contouring, is Introduced by MTF
5. Twelve Year-Old Girl With Facial Paralysis Is Smiling Again After Cutting-Edge Facial Plastic Surgery
6. Widner Oral Surgery is the First Oral Surgery Practice in Austin to Offer Perma Facial ImplantsTM
7. AAOMS Applauds Legislation Enabling Medicare Patients to Rehabilitate and Recover More Efficiently From Oral and Maxillofacial Injuries
8. New Survey Reveals The Lipstick Effect With Non-Invasive Facial Plastic Surgery Procedures
9. Oral and Maxillofacial Surgeons Applaud Congresswoman McCarthys Legislation to Require Insurance Coverage for Children With Congenital Deformities
10. Oral and Maxillofacial Surgeons Applaud Congresswoman McCarthys Resolution Raising Awareness of Preventable Facial Trauma During Sports Activities
11. New study finds increased prevalence of left-handedness in children with facial development disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 22, 2017 , ... Donor Network West, the federally-designated organ, ... announced the future opening of a CLIA certified dedicated laboratory in northern California ... determine the suitability of potential organ and tissue donors. This partnership will ...
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the ... HIV, reports Leslie Norins, MD, PhD. He says investigating this possibility, is ... Zika virus and in new infections with HIV. , His findings appear ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... imaging core lab with extensive therapeutic experience and operational excellence in oncology clinical ... immuno-oncology clinical trial for the treatment of non-small cell lung cancer and small ...
(Date:3/22/2017)... OK (PRWEB) , ... March 22, 2017 , ... ... insurance and financial planning services to regional families and business owners, is joining ... support to young people in the area. , A growing number of Oklahoma ...
(Date:3/22/2017)... ... March 22, 2017 , ... College basketball surges to its peak ... for recruiting – that is, recruiting people to be foster parents. Through a televised ... who are in foster care due to abuse, neglect and other family challenges. People ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 TFS is ... and Mr. Ed Tumaian , two global executive positions in ... be joining the Operational Leadership Team and will report to Dr. ... ... comes to TFS with 10 years of medical and scientific expertise ...
(Date:3/22/2017)... ROCKVILLE, Md. , March 22, 2017 ... that should be important to those following the industry.  This ... point-of-care (POC) RSV test, and the POC testing market ... grow. An Alere subsidiary is facing a legal battle ... Meanwhile, Beckman Coulter launched a new chemistry ...
(Date:3/22/2017)... CLARA, Calif. , March 22, 2017 /PRNewswire/ ... cardiology  solutions segment, Frost & Sullivan recognizes GE ... Company of the Year Award. GE Healthcare,s strategy ... end-to-end cardiac solutions has allowed it to effectively ... cardiac monitoring products space. In addition to aiding ...
Breaking Medicine Technology: